Peptide
Chitomur
Also known as
A-12 · A-12 bladder bioregulator · bladder cytomax · Khavinson bladder complex · Chitomur peptide
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Identity | An animal-bladder peptide mixture, also called A-12 in the Cytomax family, discussed for urgency, leakage and nighttime bathroom trips. |
|---|---|
| Usual form | The accounts concern oral tablets or capsules. Vesilute is a different synthetic peptide; its injection amounts cannot be transferred to Chitomur. |
Notes
A-12 is a bladder-tissue mixture. Cytomax names the tissue-extract family. Capsules contain animal-bladder peptides; the target name does not demonstrate exclusive delivery to the bladder.
Chitomur is discussed for urgency, leakage and waking at night to urinate. Reports include improvement, no change and bladder pain; they do not establish that the product repairs bladder tissue.
Vesilute is a different identity. Community comparisons pair Chitomur with the synthetic bladder peptide Vesilute. They are not interchangeable milligram for milligram. The Chitomur accounts here concern oral tablets or capsules; an injectable bladder-peptide discussion may concern another product. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30)
Source context — Overactive bladder? — Chitomur comment and follow-up: One anonymous account across two comments; products, amounts, diagnoses and benefit unverified. Proposed switch/repeat not completed. Visible comments only.
What people notice
| Quieter urgency | One tablet user reported improvement with continuing bladder tension around three weeks. A family account described nighttime trips falling from about three to one during Chitomur plus Ventfort, vibration-plate use and light therapy. |
|---|---|
| No improvement | Two people described no benefit, including one after 30 days of Libidon plus Chitomur. These accounts do not establish a response rate or bladder-tissue repair. |
Notes
Less urgency and fewer disrupted nights. The practical goals are fewer sudden toilet trips, less leakage and better sleep. One Reddit tablet user reported improvement but still felt bladder tension around three weeks. A different thread contains two people reporting no effect, including one after 30 days of Libidon plus Chitomur. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30) · Libidon and Chitomur peptides didn’t help at all (Personal report · Accessed 2026-09-30)
Fewer night trips in one family account. An older account described an elderly woman going from roughly three nighttime trips to one while using Chitomur and Ventfort. Blood pressure also changed, and vibration-plate use and light therapy overlapped. This cannot isolate Chitomur's contribution.
No effect is a real outcome. The 30-day nonresponder described years of worsening symptoms, leakage and nighttime urination. A separate commenter reported the same lack of benefit after trying both products, with longstanding symptoms worse around menopause. Neither account supplies a dose or verifies why it failed. Libidon and Chitomur peptides didn’t help at all (Personal report · Accessed 2026-09-30)
Cost influences comparisons with Vesilute. The improving Reddit user planned to try cheaper Vesilute when their tablets ran out. That is an intention, not a completed comparison proving either product better. Their description of feeling as though the bladder was healing is a personal impression, not evidence of tissue repair. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30)
Source context — Overactive bladder? — Chitomur comment and follow-up: One anonymous account across two comments; products, amounts, diagnoses and benefit unverified. Proposed switch/repeat not completed. Visible comments only.
Source context — Libidon and Chitomur peptides didn’t help at all: Two distinct users, not a prevalence estimate. Combined products, unspecified doses and unverified diagnoses. Username does not imply diabetes; OP explicitly denies it.
Doses people talk about
| Oral charts | Label-style charts describe 10 mg complex per capsule, with either 1–2 or 2–4 capsules, 1–2 times daily. Directions disagree about food; neither chart establishes a user norm. |
|---|---|
| One family log | 20 mg twice daily at breakfast and dinner, totaling 40 mg/day, for roughly a month. Ventfort was separately reported at 10 mg twice daily, totaling 20 mg/day. |
| Different seller chart | An advertisement lists 1–2 capsules, 2–3 times daily before meals. This is promotional copy, separate from a first-person dose report. |
Notes
Oral charts: 10 mg complex per capsule. Charts list 1–2 or 2–4 capsules, 1–2 times daily. Food directions conflict: with meals or mornings 30 minutes before food. Neither chart establishes a user norm.
One oral family log: 20 mg twice daily, totaling 40 mg/day. The account specifies breakfast and dinner during a roughly month-long course. It also used Ventfort 10 mg twice daily, totaling 20 mg/day. These are separate component amounts, not a premixed ratio or an isolated Chitomur result.
A seller's Reddit dose chart. 1–2 capsules, 2–3 times daily, 15–20 minutes before meals. This promotion does not describe a first-person dose report. Seller's Chitomur directions posted to Reddit (Secondhand community claim · Accessed 2026-09-30)
Source context — Seller's Chitomur directions posted to Reddit: Advertisement, not independent community experience or human effectiveness evidence. Multiple search results repeat the same seller copy and are not counted separately. Original commercial family is peptide-bioregulator.com/de; storefront links were not opened and are not purchase recommendations.
Half-life, onset & duration
| Felt onset | Improvement was reported by about three weeks in one account, with the first noticeable day unstated. Another found no improvement at 30 days. |
|---|---|
| Felt duration | No dependable per-tablet or after-stopping duration is documented. Expectations of lasting relief between courses are not measured symptom-free periods. |
| Half-life | An oral human value is not established. A commercial guide's 15–30-minute estimate mixes oral and injectable descriptions without a matching measurement. |
Notes
Improvement by about three weeks in one Reddit account. The commenter started January 1 and later described improvement with continuing tension. The first noticeable day is unstated. Another account found no improvement at 30 days, so these checkpoints do not establish a predictable onset window. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30) · Libidon and Chitomur peptides didn’t help at all (Personal report · Accessed 2026-09-30)
No dependable per-dose or post-course duration. The Reddit reports describe outcomes during repeated use, not a measured effect after one tablet or after stopping. Community calendars anticipate a lasting effect between courses, but that expectation is not a documented symptom-free interval. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30) · Libidon and Chitomur peptides didn’t help at all (Personal report · Accessed 2026-09-30)
15–30 minutes appears in one commercial peptide guide. Coach Cam lists this estimate while mixing injectable and oral descriptions. No matching Chitomur half-life measurement is shown. Its origin remains unresolved, and it cannot establish an oral human value. Half-life measures an amount falling by half, not how long urinary relief lasts. Coach Cam — Chitomur quick facts and half-life FAQ (Community guide · Accessed 2026-09-30)
Source context — Overactive bladder? — Chitomur comment and follow-up: One anonymous account across two comments; products, amounts, diagnoses and benefit unverified. Proposed switch/repeat not completed. Visible comments only.
Source context — Libidon and Chitomur peptides didn’t help at all: Two distinct users, not a prevalence estimate. Combined products, unspecified doses and unverified diagnoses. Username does not imply diabetes; OP explicitly denies it.
Source context — Coach Cam — Chitomur quick facts and half-life FAQ: Promotes paid coaching/community and affiliate products. Mixes tissue extract with cytogen/injectable language. No matching half-life measurement or route-specific experiment shown for its 15–30-minute number. Linked papers not all opened; not used to establish effectiveness or reproduce injection quantities.
Cycles people discuss
| Competing calendars | One commenter repeats 2–4 weeks on, about a month off. Copied charts describe 20–30-day blocks or 10-day repeats every 1–3 months; another seller says every 3–6 months. None establishes an effective repeat schedule. |
|---|
Notes
One commenter repeats 2–4 weeks, then about a month off. They mention an uncompleted 10–20-day repeat. Copied charts say 20–30-day blocks, 2–3 yearly, or 10-day repeats every 1–3 months. These competing calendars are untested. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30)
The seller's repeat chart. 10-day courses, repeated every 3–6 months. Neither this promotion nor user discussion establishes a safe, effective maintenance schedule. Seller's Chitomur directions posted to Reddit (Secondhand community claim · Accessed 2026-09-30)
Source context — Overactive bladder? — Chitomur comment and follow-up: One anonymous account across two comments; products, amounts, diagnoses and benefit unverified. Proposed switch/repeat not completed. Visible comments only.
Source context — Seller's Chitomur directions posted to Reddit: Advertisement, not independent community experience or human effectiveness evidence. Multiple search results repeat the same seller copy and are not counted separately. Original commercial family is peptide-bioregulator.com/de; storefront links were not opened and are not purchase recommendations.
Stacks
| Urinary combinations | Libidon, Pielotax, Vladonix and Ventfort appear in organ-peptide routines. The Libidon combination has a 30-day no-benefit report; the Ventfort family account also included a vibration plate and light therapy. |
|---|---|
| Vesilute sequencing | The original profile describes using one or sequencing both. The improving Reddit user's proposed switch for cost was still a plan, without a completed comparison. |
Notes
Urinary stacks make credit difficult to assign. Libidon, Pielotax, Ventfort and Vladonix appear in organ-bioregulator combinations. Their presence does not show that they add benefit. Blood-pressure medicines, caffeine, pelvic physical therapy and simultaneous lifestyle changes can also affect the symptoms people compare.
Less urgency and fewer disrupted nights. The practical goals are fewer sudden toilet trips, less leakage and better sleep. One Reddit tablet user reported improvement but still felt bladder tension around three weeks. A different thread contains two people reporting no effect, including one after 30 days of Libidon plus Chitomur. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30) · Libidon and Chitomur peptides didn’t help at all (Personal report · Accessed 2026-09-30)
Fewer night trips in one family account. An older account described an elderly woman going from roughly three nighttime trips to one while using Chitomur and Ventfort. Blood pressure also changed, and vibration-plate use and light therapy overlapped. This cannot isolate Chitomur's contribution.
Vesilute: Synthetic counterpart. Some run one, some sequence both. [community]
Cost influences comparisons with Vesilute. The improving Reddit user planned to try cheaper Vesilute when their tablets ran out. That is an intention, not a completed comparison proving either product better. Their description of feeling as though the bladder was healing is a personal impression, not evidence of tissue repair. Overactive bladder? — Chitomur comment and follow-up (Personal report · Accessed 2026-09-30)
Source context — Overactive bladder? — Chitomur comment and follow-up: One anonymous account across two comments; products, amounts, diagnoses and benefit unverified. Proposed switch/repeat not completed. Visible comments only.
Source context — Libidon and Chitomur peptides didn’t help at all: Two distinct users, not a prevalence estimate. Combined products, unspecified doses and unverified diagnoses. Username does not imply diabetes; OP explicitly denies it.
Watch for
| Bladder pain | One retailer-page reviewer described pain during two attempts, worse with two capsules than one. Serious existing bladder and nerve problems and earlier Endoluten co-use prevent a clear cause. |
|---|---|
| Contents and tolerability | Stomach upset and animal-tissue sensitivity are discussed. Long-term safety, pregnancy safety and medicine interactions are not established by these accounts. |
| Urinary warning signs | Inability to urinate or severe abdominal pain needs immediate medical attention. Frequent small trips or leakage can reflect retention; blood in urine, fever and infection also need assessment. |
Notes
Bladder pain was reported during two attempts. On a Russian retailer's discussion page, Irina describes aching with one capsule and stronger pain with two. An earlier course included Endoluten and ended because of pain. Significant pre-existing bladder and nerve problems complicate attribution. This is one person's account, not two independent reports. Irina — bladder pain during Chitomur attempts (Personal report · Accessed 2026-09-30)
Animal-tissue products have unresolved safety questions. Community cautions include stomach upset, sensitivity and uncertain contents. Pregnancy safety, medicine interactions and long-term use are not established by these accounts or the inspected study abstract. A seller's claim of no side effects cannot settle those questions. Seller's Chitomur directions posted to Reddit (Secondhand community claim · Accessed 2026-09-30) · Gomberg, Ryzhak and Lyutov — bladder-function study in women (2013) (Official context · Accessed 2026-09-30)
Trouble emptying the bladder needs assessment. NIDDK explains that retention can cause frequent small trips and leakage. Inability to urinate or severe abdominal pain needs immediate medical attention. The community record also warns against overlooking blood in urine, fever or infection while pursuing another peptide. NIDDK — symptoms and causes of urinary retention (Official context · Accessed 2026-09-30)
Source context — Irina — bladder pain during Chitomur attempts: Commercial host; review identity and moderation unknown. Russian text paraphrased directly, not an independent clinical report. Same woman describes two attempts separated by two years; 2022 course co-used Endoluten, stopped after pain, and involved serious existing bladder/nerve dysfunction. Site includes unsafe promotional reassurances and regimens that are not adopted.
Source context — Seller's Chitomur directions posted to Reddit: Advertisement, not independent community experience or human effectiveness evidence. Multiple search results repeat the same seller copy and are not counted separately. Original commercial family is peptide-bioregulator.com/de; storefront links were not opened and are not purchase recommendations.
Source context — Gomberg, Ryzhak and Lyutov — bladder-function study in women (2013): Actual abstract fetched through urllib after web PubMed returned only a footer and Europe PMC page/API web opens failed. Abstract only; no full methods, sample size, dose, route or human kinetics. First-publication API date is year-level metadata, not proof of January 1 publication.
Source context — NIDDK — symptoms and causes of urinary retention: General urinary-retention guidance, not a Chitomur study or evidence of a specific adverse mechanism.
Full notes
Chitomur is discussed for urgency, leakage and waking at night to urinate. Reports include improvement, no change and bladder pain; they do not establish that the product repairs bladder tissue.
What Chitomur actually is
- A-12 is a bladder-tissue mixture. Cytomax names the tissue-extract family. Capsules contain animal-bladder peptides; the target name does not demonstrate exclusive delivery to the bladder. Community
- Vesilute is a different identity. Community comparisons pair Chitomur with the synthetic bladder peptide Vesilute. They are not interchangeable milligram for milligram. The Chitomur accounts here concern oral tablets or capsules; an injectable bladder-peptide discussion may concern another product. Community Personal report
What people hope to notice
- Less urgency and fewer disrupted nights. The practical goals are fewer sudden toilet trips, less leakage and better sleep. One Reddit tablet user reported improvement but still felt bladder tension around three weeks. A different thread contains two people reporting no effect, including one after 30 days of Libidon plus Chitomur. Personal report Personal report Community
- Fewer night trips in one family account. An older account described an elderly woman going from roughly three nighttime trips to one while using Chitomur and Ventfort. Blood pressure also changed, and vibration-plate use and light therapy overlapped. This cannot isolate Chitomur's contribution. Community
Doses people discuss
Reported amounts and copied charts describe different things. These are not instructions, and capsule counts depend on the particular product.
- Oral charts: 10 mg complex per capsule. Charts list 1–2 or 2–4 capsules, 1–2 times daily. Food directions conflict: with meals or mornings 30 minutes before food. Neither chart establishes a user norm. Community
- One oral family log: 20 mg twice daily, totaling 40 mg/day. The account specifies breakfast and dinner during a roughly month-long course. It also used Ventfort 10 mg twice daily, totaling 20 mg/day. These are separate component amounts, not a premixed ratio or an isolated Chitomur result. Community
- A seller's Reddit dose chart. 1–2 capsules, 2–3 times daily, 15–20 minutes before meals. This promotion does not describe a first-person dose report. Reddit — commercial seller account
Half-life
- 15–30 minutes appears in one commercial peptide guide. Coach Cam lists this estimate while mixing injectable and oral descriptions. No matching Chitomur half-life measurement is shown. Its origin remains unresolved, and it cannot establish an oral human value. Half-life measures an amount falling by half, not how long urinary relief lasts. Community guide
Onset: when a change is noticed
- Improvement by about three weeks in one Reddit account. The commenter started January 1 and later described improvement with continuing tension. The first noticeable day is unstated. Another account found no improvement at 30 days, so these checkpoints do not establish a predictable onset window. Personal report Personal report
Duration: how long improvement lasts
- No dependable per-dose or post-course duration. The Reddit reports describe outcomes during repeated use, not a measured effect after one tablet or after stopping. Community calendars anticipate a lasting effect between courses, but that expectation is not a documented symptom-free interval. Personal report Personal report Community
Cycles and time off
- One commenter repeats 2–4 weeks, then about a month off. They mention an uncompleted 10–20-day repeat. Copied charts say 20–30-day blocks, 2–3 yearly, or 10-day repeats every 1–3 months. These competing calendars are untested. Personal report Community
- The seller's repeat chart. 10-day courses, repeated every 3–6 months. Neither this promotion nor user discussion establishes a safe, effective maintenance schedule. Reddit — commercial seller account
Good to know
- Bladder pain was reported during two attempts. On a Russian retailer's discussion page, Irina describes aching with one capsule and stronger pain with two. An earlier course included Endoluten and ended because of pain. Significant pre-existing bladder and nerve problems complicate attribution. This is one person's account, not two independent reports. Personal report
- Animal-tissue products have unresolved safety questions. Community cautions include stomach upset, sensitivity and uncertain contents. Pregnancy safety, medicine interactions and long-term use are not established by these accounts or the inspected study abstract. A seller's claim of no side effects cannot settle those questions. Community Reddit — commercial seller account Official context
- Trouble emptying the bladder needs assessment. NIDDK explains that retention can cause frequent small trips and leakage. Inability to urinate or severe abdominal pain needs immediate medical attention. The community record also warns against overlooking blood in urine, fever or infection while pursuing another peptide. Official context Community
From community discussion
- Cost influences comparisons with Vesilute. The improving Reddit user planned to try cheaper Vesilute when their tablets ran out. That is an intention, not a completed comparison proving either product better. Their description of feeling as though the bladder was healing is a personal impression, not evidence of tissue repair. Personal report
- No effect is a real outcome. The 30-day nonresponder described years of worsening symptoms, leakage and nighttime urination. A separate commenter reported the same lack of benefit after trying both products, with longstanding symptoms worse around menopause. Neither account supplies a dose or verifies why it failed. Personal report
- Urinary stacks make credit difficult to assign. Libidon, Pielotax, Ventfort and Vladonix appear in organ-bioregulator combinations. Their presence does not show that they add benefit. Blood-pressure medicines, caffeine, pelvic physical therapy and simultaneous lifestyle changes can also affect the symptoms people compare. Community Community Community
What the human research adds
- A 2013 study concerned women aged 48–80. The randomized blind study's abstract reports fewer urgent urges and leakage episodes, improved self-assessed quality of life and no detected side effects. It omits participant count, dose, route and half-life. That limited report cannot establish a community schedule or comprehensive safety. Official context
- Older-male claims have a different provenance. The community record repeats secondary Khavinson summaries about improved urination measures in older men. Those are not the same population as the female study and are not verified here as an independent trial. They do not prove relief of prostate obstruction. Community
